Literature DB >> 5216403

Syndrome resembling Addison's disease following prolonged treatment with busulphan.

B P Harrold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5216403      PMCID: PMC1843625          DOI: 10.1136/bmj.1.5485.463

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY.

Authors:  E LEAKE; W G SMITH
Journal:  Lancet       Date:  1963-08-31       Impact factor: 79.321

2.  Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy.

Authors:  A HAUT; W S ABBOTT; M M WINTROBE; G E CARTWRIGHT
Journal:  Blood       Date:  1961-01       Impact factor: 22.113

3.  Interstitial pulmonary fibrosis following busulfan therapy.

Authors:  H OLINER; R SCHWARTZ; F RUBIO; W DAMESHEK
Journal:  Am J Med       Date:  1961-07       Impact factor: 4.965

4.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

5.  [1-4 Dimetanosulfoniloxibutano (GT 41 - myleran) in the treatment of chronic myelogenous leukemia].

Authors:  H M MARINHO; P C MARTINS
Journal:  Arq Bras Med       Date:  1956 May-Jun

6.  A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.

Authors:  R A KYLE; R S SCHWARTZ; H L OLINER; W DAMESHEK
Journal:  Blood       Date:  1961-11       Impact factor: 22.113

  6 in total
  5 in total

Review 1.  Drug eruptions.

Authors:  S K Goolamali
Journal:  Postgrad Med J       Date:  1985-10       Impact factor: 2.401

2.  Busulphan lung.

Authors:  B E Heard; R A Cooke
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

Review 3.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung.

Authors:  H Stott; R Stephens; W Fox; G Simon; D C Roy
Journal:  Thorax       Date:  1976-06       Impact factor: 9.139

5.  Endocrine sequelae of cancer and cancer treatments.

Authors:  Charles J Stava; Camilo Jimenez; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-11-20       Impact factor: 4.442

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.